Skip to main content
search

Dr. Crystal M. Glover visits Cameroon for AAIC Neuroscience Next

Dr. Crystal M. Glover of UCI MIND joined the Alzheimer’s Association International Conference (AAIC) Neuroscience Next in Yaoundé, Cameroon during February 24-27, 2025. AAIC Neuroscience Next scientific events took place at 12 global hubs or locations, with Yaoundé representing one site. The co-organizers of AAIC Neuroscience Next – Cameroon Hub were Dr. Alfred K. Njamnshi, Founder of the Brain Research Africa Initiative (BRAIN), and Dr. Bernard Fongang of The University of Texas Health Science Center at San Antonio. These scientific events aimed to showcase research and related efforts focused on brain health in international contexts to facilitate scientific advancements, foster collaborations, and augment training for early career researchers and students. Dr. Glover attended AAIC Neuroscience Next – Cameroon Hub in her role as Editor-In-Chief of Alzheimer’s & Dementia: Behavior & Socioeconomics of Aging (BSEA), the newest member of the Alzheimer’s & Dementia family of scientific journals hosted by the Alzheimer’s Association. In Yaoundé, she spoke about the general scope of BSEA, including focusing on the impact of and interconnections between individual, social, and structural factors on aging and dementia trajectories at local, national, and global levels. Dr. Glover indicated that BSEA widely disseminates scientific findings, perspectives, and ideas focused on diverse aging and dementia trajectories to inform, develop, and implement best practices, guidelines, interventions, materials and tools, measures, strategies, policies, and other evidence-based materials.

Related posts:

  1. LA Times article highlights ARIA A June 17 article in the Los Angeles Times highlighted an important safety risk associated with the new class of medications recently approved for treating Alzheimer’s disease. The drugs are anti-amyloid monoclonal antibodies and include aducanumab, donanemab, and lecanemab. Of these, only lecanemab has achieved full FDA approval at the...
  2. Dr. Joshua Grill and colleague from Penn publish essay on clinical implications of new drugs Breaking the Tyranny of Treatment: A New Perspective on Alzheimer’s Care...
  3. Two UCI researchers named as UCI MIND WAM at Cleveland Clinic Women’s initiative recipients Since 2017, UCI MIND has partnered with the Women’s Alzheimer’s Movement (WAM) at Cleveland Clinic, founded by Maria Shriver, to fund the Women’s Initiative. The initiative provides funding for research to better understand why women are at higher risk than men of developing Alzheimer’s disease. This year, the UCI MIND...
Close Menu